BUZZ-Tenon Medical rises on FDA approval of device to treat joint disorder

Reuters03-25

** Shares of medical device maker Tenon Medical TNON.O, RIC rise 91.2% to $1.87 premarket

** US FDA has cleared TNON's device, Catamaran SI Joint Fusion System, to treat sacroiliac (SI) joint disorders, co said on Monday

** The device serves a dual function, acting as a standalone treatment for SI joint disorders and providing support and stabilization during spinal fusion procedures

** SI joint is the connection point between the sacrum, a triangular bone at the base of spine, and the ilium, a part of pelvis

** Stock fell 87.6% in the last 12 month

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment